International Medical Center of Biomaterials Processing and Cryostorage (MOEX: GEMA)

Market Cap	10.03B
Revenue (ttm)	n/a
Net Income (ttm)	n/a
Shares Out	14.93M
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	8.65 (1.29%)
Ex-Dividend Date	n/a

Volume	90
Open	666.00
Previous Close	673.50
Day's Range	666.00 - 674.00
52-Week Range	601.00 - 1,250.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2024

About GEMA

International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company operates as a licensed bank for personal storage of cord blood stem cells and tissue of the umbilical cord in Russia and the CIS countries. The company was founded in 2003 and is based in Moscow, Russia. International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company is a subsidiary of Human Stem Cells Institute PJSC.

• Industry: Miscellaneous Health And Allied Services, Not Elsewhere Classified
• Founded: 2003
• Employees: 15
• Stock Exchange: Moscow Stock Exchange
• Ticker Symbol: GEMA

Financial Performance

In 2022, GEMA's revenue was 254.68 million, a decrease of -4.22% compared to the previous year's 265.89 million. Earnings were 98.17 million, a decrease of -34.88%.